SynDRA canonical compound SYN0002705 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | BCR |
| Mechanism of action | Abl kinase inhibitor |
| Indication | acute lymphoblastic leukemia (ALL) | aggressive systemic mastocytosis (ASM) | chronic eosinophilic leukemia (CEL) | chronic myeloid leukemia (CML) | dermatofibrosarcoma protuberans (DFSP) | gastrointestinal stromal tumors (GIST) | hypereosinophilic syndrome (HES) | myelodysplastic diseases (MDS) |
| Disease area | hematologic malignancy | oncology |